human ipsc-based disease modeling and therapeutic development
Published 3 years ago • 485 plays • Length 59:40Download video MP4
Download video MP3
Similar videos
-
25:05
generation of induced pluripotent stem cell-derived cardiomyocytes for disease modeling
-
23:59
disease modelling with human pluripotent stem cells: principles and specific applications to obesity
-
27:45
improvements in building in vitro pluripotent stem cell-derived disease models
-
16:51
using ips cell technology to model human neurodegenerative diseases
-
59:32
probing disease mechanisms in als using ipscs, reprogramming and optogenetic approaches
-
51:40
heart disease in a dish: human ipsc-derived multicellular cardiac organoids
-
1:17:30
a new era of medicine with ips cells - lecture by professor shinya yamanaka
-
7:36
the rise and fall of stem cell research
-
16:57
titan submersible location and orientation of debris field, skids and tail cone - most critical info
-
30:29
optimizing stem cells workflows to build better disease models
-
46:12
selecting the right tools to build your pluripotent stem cell based disease models
-
18:24
paul burridge: disease modeling and human ipscs
-
1:02:46
genome editing and stem cell engineering for disease modeling
-
54:40
precise gene editing of human pluripotent stem cells
-
23:22
characterization of human ipsc-derived neurons by transcriptomics and proteomics for drug discovery
-
23:25
differentiation of human pluripotent stem cells into atrial and ventricular cardiomyocyte subtypes
-
21:59
pluripotent stem cells to explore mechanisms and treatments of neuromuscular diseases
-
35:21
sps 2018: implementing human ipsc-derived cells in early safety assessment & disease modeling
-
38:35
3d organoid models for differentiation of psc-derived dopaminergic neurons
-
58:43
human ipsc-derived midbrain dopaminergic neurons for parkinson’s disease modeling and cell therapy
-
34:55
modelling disorders of the brain through patient-derived stem cells
-
1:00:59
human pluripotent stem cells in understanding genetic cardiovascular disease and effects of drugs